Literature DB >> 23941674

The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV.

Moria Shimoni1, Alon Herschhorn, Yelena Britan-Rosich, Moshe Kotler, Itai Benhar, Amnon Hizi.   

Abstract

Selecting for antibodies against specific cell-surface proteins is a difficult task due to many unrelated proteins that are expressed on the cell surface. Here, we describe a method to screen antibody-presenting phage libraries against native cell-surface proteins. We applied this method to isolate antibodies that selectively recognize CCR5, which is the major co-receptor for HIV entry (consequently, playing a pivotal role in HIV transmission and pathogenesis). We employed a phage screening strategy by using cells that co-express GFP and CCR5, along with an excess of control cells that do not express these proteins (and are otherwise identical to the CCR5-expressing cells). These control cells are intended to remove most of the phages that bind the cells nonspecifically; thus leading to an enrichment of the phages presenting anti-CCR5-specific antibodies. Subsequently, the CCR5-presenting cells were quantitatively sorted by flow cytometry, and the bound phages were eluted, amplified, and used for further successive selection rounds. Several different clones of human single-chain Fv antibodies that interact with CCR5-expressing cells were identified. The most specific monoclonal antibody was converted to a full-length IgG and bound the second extracellular loop of CCR5. The experimental approach presented herein for screening for CCR5-specific antibodies can be applicable to screen antibody-presenting phage libraries against any cell-surface expressed protein of interest.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23941674      PMCID: PMC3739959          DOI: 10.1089/vim.2012.0029

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  61 in total

Review 1.  Intrabodies as antiviral agents.

Authors:  W A Marasco
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

2.  Global chromosome positions are transmitted through mitosis in mammalian cells.

Authors:  Daniel Gerlich; Joël Beaudouin; Bernd Kalbfuss; Nathalie Daigle; Roland Eils; Jan Ellenberg
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

5.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

6.  Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.

Authors:  A Trkola; T J Ketas; K A Nagashima; L Zhao; T Cilliers; L Morris; J P Moore; P J Maddon; W C Olson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.

Authors:  Cédric Blanpain; Jean-Marie Vanderwinden; Josef Cihak; Valérie Wittamer; Emmanuel Le Poul; Hassan Issafras; Manfred Stangassinger; Gilbert Vassart; Stefano Marullo; Detlef Schlndorff; Marc Parmentier; Matthias Mack
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

8.  Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities.

Authors:  Changhua Ji; Michael Brandt; Marianna Dioszegi; Andreas Jekle; Stephan Schwoerer; Steven Challand; Jun Zhang; Yun Chen; Lisa Zautke; Gunthar Achhammer; Monika Baehner; Sandra Kroetz; Gabrielle Heilek-Snyder; Ralf Schumacher; Nick Cammack; Surya Sankuratri
Journal:  Antiviral Res       Date:  2006-12-05       Impact factor: 5.970

9.  The production of a genus-specific recombinant antibody (scFv) using a recombinant potyvirus protease.

Authors:  Michael Hust; Edgar Maiss; Hans-Jörg Jacobsen; Thomas Reinard
Journal:  J Virol Methods       Date:  2002-12       Impact factor: 2.014

Review 10.  CCR5 monoclonal antibodies for HIV-1 therapy.

Authors:  William C Olson; Jeffrey M Jacobson
Journal:  Curr Opin HIV AIDS       Date:  2009-03       Impact factor: 4.283

View more
  1 in total

1.  Rapid On-Cell Selection of High-Performance Human Antibodies.

Authors:  David N Philpott; Surath Gomis; Hansen Wang; Randy Atwal; Abdellali Kelil; Tanja Sack; Brandon Morningstar; Chris Burnie; Edward H Sargent; Stephane Angers; Sachdev Sidhu; Shana O Kelley
Journal:  ACS Cent Sci       Date:  2021-12-29       Impact factor: 14.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.